Stockreport

FDA Scientific Advisory Committee Discusses 22nd Century Group’s Reduced Nicotine Cigarettes

22nd Century Group, Inc  (XXII) 
NASDAQ:AMEX Investor Relations: xxiicentury.com
PDF 22nd Century Group and FDA presented information regarding 22nd Century’s Modified Risk Tobacco Product marketing application for its proprietary VLN® and VLN® Menthol R [Read more]